These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32146997)

  • 21. [Metformin and kidneys].
    Smahelová A
    Vnitr Lek; 2008 May; 54(5):535-40. PubMed ID: 18630642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy: Risk of metformin use in patients with T2DM and advanced CKD.
    Schernthaner G; Schernthaner-Reiter MH
    Nat Rev Endocrinol; 2015 Dec; 11(12):697-9. PubMed ID: 26284445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality and metformin use in patients with advanced chronic kidney disease--Authors' reply.
    Hung SC; Chang YK; Liu JS; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Sep; 3(9):681. PubMed ID: 26298571
    [No Abstract]   [Full Text] [Related]  

  • 24. Metformin for patients with diabetes and concomitant renal restrictions--is there an evidence base?
    Sharif A
    QJM; 2013 Mar; 106(3):291-4. PubMed ID: 23349404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Association between Metformin Therapy and Lactic Acidosis.
    Kuan IHS; Savage RL; Duffull SB; Walker RJ; Wright DFB
    Drug Saf; 2019 Dec; 42(12):1449-1469. PubMed ID: 31372935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin therapy in patients with chronic kidney disease.
    Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO
    Diabetes Obes Metab; 2012 Oct; 14(10):963-5. PubMed ID: 22564555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin in chronic kidney disease: a strong dose of caution.
    Hanna RM; Rhee CM; Kalantar-Zadeh K
    Kidney Int; 2020 Nov; 98(5):1101-1105. PubMed ID: 33126975
    [No Abstract]   [Full Text] [Related]  

  • 28. Metformin in patients with chronic kidney disease: strengths and weaknesses.
    Rocha A; Almeida M; Santos J; Carvalho A
    J Nephrol; 2013; 26(1):55-60. PubMed ID: 22641582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin nephrotoxicity insights: will they change clinical management?
    Thomas CC; Bakris G
    J Diabetes; 2014 Mar; 6(2):111-2. PubMed ID: 24274706
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription-medication sharing among family members: an unrecognized cause of a serious drug adverse event in a patient with impaired renal function.
    Makówka A; Zawiasa A; Nowicki M
    Clin Nephrol; 2015 Mar; 83(3):196-200. PubMed ID: 24691009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications.
    Vaughan EM; Rueda JJ; Samson SL; Hyman DJ
    Curr Diabetes Rev; 2020; 16(8):851-858. PubMed ID: 32026779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A risk-benefit assessment of metformin in type 2 diabetes mellitus.
    Howlett HC; Bailey CJ
    Drug Saf; 1999 Jun; 20(6):489-503. PubMed ID: 10392666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin-induced lactic acidosis: usefulness of measuring levels and therapy with high-flux haemodialysis.
    Martin Gómez MA; Sánchez Martos MD; García Marcos SA; Serrano Carrillo de Albornoz JL
    Nefrologia; 2011; 31(5):610-1. PubMed ID: 21959733
    [No Abstract]   [Full Text] [Related]  

  • 34. Metformin and serious adverse effects.
    Nisbet JC; Sturtevant JM; Prins JB
    Med J Aust; 2004 Jan; 180(2):53-4. PubMed ID: 14723582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment.
    Scheen AJ
    Evid Based Med; 2015 Jun; 20(3):115. PubMed ID: 25827139
    [No Abstract]   [Full Text] [Related]  

  • 36. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemodialysis-refractory metformin-associated lactate acidosis with hypoglycemia, hypothermia, and bradycardia in a diabetic patient with belated diagnosis and chronic kidney disease
.
    Zibar L; Zibar K
    Int J Clin Pharmacol Ther; 2017 Apr; 55(4):348-351. PubMed ID: 28139970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metformin and anesthesia].
    Landgraf R; Nawroth PP
    Anaesthesist; 2002 Jun; 51(6):491-2. PubMed ID: 12452166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.